Related Experiment Video
Updated: Aug 14, 2026

16:24
Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Gene expression profiling in human endometrial cancer tissue samples: utility and diagnostic value
E Smid-Koopman1, L J Blok, Th J M Helmerhorst
1Department of Obstetrics and Gynecology, Erasmus Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands. esmidkoopman@hotmail.com
Gynecologic Oncology
|April 22, 2004
Summary
Gene expression profiling accurately classified endometrial cancer subgroups, mirroring traditional histopathologic grading. This technique offers a novel approach to understanding tumor behavior and patient prognosis.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Gene expression profiling identifies novel cancer subgroups beyond conventional staging.
- Endometrial carcinomas require improved methods for biological behavior classification.
Purpose of the Study:
- To evaluate the clinical utility and prognostic significance of gene expression profiling in endometrial carcinomas.
- To compare gene expression profiles with established histopathologic staging.
Main Methods:
- Utilized a macro cDNA array with 588 cancer-related genes.
- Generated gene expression profiles from 12 endometrial cancer, 3 benign endometrial, and 3 myometrial tissue samples.
- Employed cluster analysis to differentiate tissue types and tumor subgroups.
Main Results:
- Achieved 77% efficacy in generating gene expression profiles, demonstrating high reproducibility.
- Gene expression profiles were tissue-specific, distinguishing tumors from benign and myometrial tissues.
- Cluster analysis identified two distinct endometrial tumor subgroups with high similarity to FIGO grading.
Conclusions:
- Gene expression profiling effectively classifies endometrial tumors, correlating with FIGO grading.
- This molecular approach provides a new dimension for understanding endometrial cancer heterogeneity.
- The findings support the potential of gene expression profiling for improved prognostic assessment.

